Frontiers in pharmaceutical nanotechnology

  1. editorImage
  1. Editor: Prof. Matthias G. Wacker
    National University of Singapore

Today, a wide spectrum of nanomedicines is being developed for the diagnosis, prevention and treatment of disease. Recent breakthroughs include the delivery of small molecules, therapeutic proteins or peptides, and great progress has been made in the material design and targeting of nanocarriers to specific tissues or across biological barriers. However, converting the strategies into products is still challenging, and many nanomedicines fail to comply with the market requirements or during the clinical trials.

This thematic issue aims to present recent research in the design, manufacture and testing of nanomedicines. Potential contributions may include, but are not limited to the following topics:

  • Development of drug delivery systems for pharmaceuticals and biopharmaceuticals (small molecules, proteins, nucleic acids)
  • Manufacturing and biomedical aspects of drug product design
  • Strategies and formulations for controlled drug transport across biological barriers
  • Physicochemical aspects of drug product development
  • Novel excipients for drug product design
  • Drug delivery and controlled release systems for systemic and local applications
  • Nanomaterials for therapeutic and diagnostic purposes

This thematic issue is dedicated to Prof. Dr. Jörg Kreuter, a pioneer of this whole research area, whose contributions have been widely recognized. With more than 300 publications, he has shaped pharmaceutical nanotechnology for the last 40 years.

Submission Deadline: April 30, 2019

Keep Informed

RSS Feed

Subscribe to our Latest Articles RSS Feed.


Follow the Beilstein-Institut


Twitter: @BeilsteinInst